Transcode Therapeutics, Inc. (RNAZ) IPO - S-1 Filing, Stock & Insider Activity
Transcode Therapeutics, Inc. IPO - Status & S-1 Filing
- Ticker: RNAZ
- Status: Registered - S-1 filed with the SEC
- S-1 filed: 2026-05-01
- Exchange: NASDAQ
- Expected price range: not yet disclosed (set in a later S-1/A or pricing amendment)
- Shares offered: 1,533,334
- SEC CIK: 0001829635 · View the S-1 on SEC EDGAR →
Transcode Therapeutics, Inc. is pre-IPO, so no insider Form 4 transactions have been filed yet. Once insiders begin reporting trades after the offering, they will appear on this page automatically.
Track every registration update on the InsiderAlpha IPO tracker.
Transcode Therapeutics, Inc. (RNAZ) - no SEC Form 4 insider filings recorded in the last 90 days. 9 Form 8-K material event filings were reported by RNAZ in the last 90 days. InsiderAlpha tracks every RNAZ SEC filing - Form 4, Form 144, and 8-K - in real time, including Rule 10b5-1 plan detection.
About Transcode Therapeutics, Inc. (RNAZ)
Transcode Therapeutics, Inc. trades under the ticker RNAZ.
| SEC CIK | 0001829635 |
|---|
90-Day SEC Filing Activity
| Form 8-K filings (90d) | 9 |
|---|
Recent RNAZ Form 8-K Material Events
- - Item 3.03, 5.03, 9.01 [SEC]
- - Item 5.07 [SEC]
- - Item 3.03, 5.03, 9.01 [SEC]
- - Item 8.01 [SEC]
- - Item 7.01, 9.01 [SEC]
Form 4 Transaction Code Reference
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in RNAZ insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
RNAZ Insider Trading - FAQ
- What is the latest insider trade for RNAZ?
- Transcode Therapeutics, Inc. (RNAZ) had 0 insider filings in the last 90 days. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
- How many insiders are buying RNAZ stock?
- 0 insider purchases of RNAZ were filed in the last 90 days.
- How many insiders are selling RNAZ stock?
- 0 insider sales of RNAZ were filed in the last 90 days.
- Where can I see RNAZ SEC filings (Form 4, 10-K, 10-Q, 8-K)?
- This page tracks RNAZ Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Companies with Insider Activity
Other companies in the InsiderAlpha index with a significant SEC Form 4 insider-trading footprint:
- $ROC Rank One Computing Corp dba ROC
- $RONE ReserveOne Holdings, Inc.
- $ROZE ROZE AI INC.
- $RPGL Republic Power Group Ltd
- $RREV RRE Ventures Acquisition Corp.
- $RSHL Rise Smart Group Holdings Ltd
- $RTMVF Rightmove PLC/ADR
- $RUBI Rubico Inc.
- $RVI Robinhood Ventures Fund I
- $RVRC Revium Rx.
Learn More
- What is SEC Form 4?
- How to read insider buying signals
- Rule 10b5-1 trading plans explained
- The cluster buying signal
Open the live RNAZ dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.